Mycenax Biotech Inc. is a fully dedicated biologics CDMO company with experience in developing various types of biologics, such as recombinant proteins, enzymes, antibodies, antibody-drug conjugates (ADC), and gene and cell therapy products.
Our GMP facility, certified by Taiwan FDA and audited by EU QPs and global clients/regulatory agencies extensively, employs modern digital systems to ensure consistent compliance with GMP standards in accordance with regulations from EU, Japan, US, and PIC/...S.
Mycenax is your best partner for developing biologics.
Mycenax is a fully dedicated CDMO (Contract Development and Manufacturing Organization) specializing in process development and cGMP manufacturing for innovative biologics and biosimilar products.
Leveraging extensive expertise, we provide a comprehensive range of solutions, including small peptides, fusion proteins, monoclonal antibodies, vaccines, bi/multi-specific antibodies, ADCs/PDCs, plasmid DNA, and cell therapy products.
Using advanced platforms and two PIC/S GMP-compliant manufacturing facilities, we offer efficient and cost-effective one-stop services from DNA to Drug Product to clients globally